Alumni Capital LP and Affiliates File Schedule 13G for RedHill Biopharma Ltd.

Alumni Capital LP, along with its general partner Alumni Capital GP LLC and controlling person Ashkan Mapar, filed a Schedule 13G with the SEC regarding their beneficial ownership of American Depository Shares (ADS) of RedHill Biopharma Ltd. The filing indicates that the Reporting Persons collectively own 369,373 ADS, representing 9.99% of the outstanding shares. The ADS are held through various agreements, including a Purchase Agreement, Pre-Funded Warrants, and Commitment Warrants, which allow the Fund to acquire additional ADS subject to certain ownership limitations. The Reporting Persons disclaim beneficial ownership of the ADS except to the extent of their pecuniary interest. The filing is made pursuant to Rule 13d-1(c) of the Securities Exchange Act of 1934.